We thank Baklouti et al. (1) for commenting on our population pharmacokinetic study of dalbavancin for optimal treatment of adult patients with staphylococcal osteoarticular infections (2) and for suggesting that our model tends to underestimate the concentrations observed in a group of French patients (French group).….
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" / Cojutti, Pier Giorgio; Rinaldi, Matteo; Zamparini, Eleonora; Rossi, Nicolò; Tedeschi, Sara; Conti, Matteo; Pea, Federico; Viale, Pierluigi. - In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. - ISSN 0066-4804. - ELETTRONICO. - 66:1(2022), pp. e01908-21.1-e01908-21.1. [10.1128/AAC.01908-21]
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?"
Cojutti, Pier Giorgio;Rinaldi, Matteo;Tedeschi, Sara;Pea, Federico;Viale, Pierluigi
2022
Abstract
We thank Baklouti et al. (1) for commenting on our population pharmacokinetic study of dalbavancin for optimal treatment of adult patients with staphylococcal osteoarticular infections (2) and for suggesting that our model tends to underestimate the concentrations observed in a group of French patients (French group).….I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
